Doctor profile · Federal record
Dr. MOLLY DAVIS, NP-C
Gerontology Nurse Practitioner (CMS: NURSE PRACTITIONER) · Adult Health Nurse Practitioner · DENVER, CO
- NPI 1467114322
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 5 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1800 N WILLIAMS ST STE 200
DENVER, CO 802181237
(303) 388-4876 - Mailing address
-
PO BOX 911230
DALLAS, TX 753911230
Credentials & registration
- NPI registered
- October 2021 — 5 yrs on file
- Profile last updated
- March 21, 2023
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363LG0600X — NUCC code
- State licenses (2)
- Texas #1109034 · Colorado #0997014-NP
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467114322. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
536
Distinct HCPCS
9
Medicare allowed
$30,224
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 205 | 135 | $104 | |
36415 |
Insertion of needle into vein for collection of blood sample | 91 | 52 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 70 | 46 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 60 | 39 | $10 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 31 | 31 | $146 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 27 | 24 | $73 | |
83540 |
Iron level | 18 | 17 | $6 | |
83550 |
Iron binding capacity | 18 | 17 | $9 | |
82728 |
Ferritin (blood protein) level | 16 | 15 | $13 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 65. This provider delivers 8.2× the peer median.Open Payments
Industry payments received
All-time total
$1,362
Transactions
44
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $181.56 | |
| PFIZER INC. | 5 | $120.75 | |
| Janssen Biotech, Inc. | 5 | $96.84 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $84.88 | |
| Blueprint Medicines Corporation | 3 | $81.47 | |
| Eisai Inc. | 3 | $79.06 | |
| Celgene Corporation | 4 | $75.82 | |
| Daiichi Sankyo Inc. | 2 | $57.54 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56.56 | |
| ACADIA Pharmaceuticals Inc | 1 | $53.59 | |
| ABBVIE INC. | 2 | $43.60 | |
| AstraZeneca Pharmaceuticals LP | 2 | $42.73 | |
| TAIHO ONCOLOGY, INC. | 2 | $36.76 | |
| PharmaEssentia USA Corporation | 1 | $34.87 | |
| EMD Serono, Inc. | 1 | $33.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
59
Patients
41
Total drug cost
$573
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Hcl | Generic | 34 | 27 | $371 |
| Prochlorperazine Maleate | Generic | 14 | 14 | $152 |
| Gabapentin | Generic | 11 | 0 | $50 |